Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8835459 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US9289387 | BTCP PHARMA | Method of treating pain by administering sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US10610523 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US10016403 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US9642844 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US8835460 | BTCP PHARMA | Sublingual fentanyl spray and methods of treating pain |
Jan, 2027
(2 years from now) | |
US9241935 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(2 years from now) | |
US9642797 | BTCP PHARMA | Sublingual fentanyl spray and methods of use to treat pain |
Jan, 2027
(2 years from now) | |
US8486973 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) | |
US8486972 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Jan 04, 2015 |
Market Authorisation Date: 04 January, 2012
Treatment: Treatment of pain
Dosage: SPRAY;SUBLINGUAL